03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Hospital transactional activity has soared over the last decade, and many public hospitals are evalu...
Read More >
The frank discussion during the roundtable highlighted contractors’ ongoing concerns regarding OFCC...
Read More >
On April 23, Kramer Levin reported on the European Parliament’s approved proposal for the adoption ...
Read More >
Continuing focus on sexual harassment - The EHRC has published technical guidance on sexual harassm...
Read More >
On December 16, 2019, the IRS issued proposed regulations under Section 162(m) of the Internal Reven...
Read More >
Investments in private companies by way of share purchases from existing shareholders (secondary tra...
Read More >